Adverse Effects of a Clinically Relevant Dose of Hydroxyurea Used for the Treatment of Sickle Cell Disease on Male Fertility Endpoints

International Journal of Environmental Research and Public Health

Volumn 6, Issue 3, 2009, Pages 1124-1144

  Jones, Kea M ^a   Niaz, Mohammad S ^a   Brooks, Cynthia M ^a   Roberson, Shannon I ^a   Aguinaga, Maria P ^a   Hills, Edward R ^a   Rice, Valerie Montgomery ^a   Bourne, Phillip ^a   Bruce, Donald ^a   Archibong, Anthony E ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Hydroxyurea; Hypogonadism; Sickle cell disease; Spermatozoa, testosterone; Testicular failure; Transgenic sickle cell mouse

Indexed keywords

HYDROXYUREA; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; HYPOGONADISM; LEYDIG CELL; MALE; MALE FERTILITY; MOUSE; NONHUMAN; SEMINIFEROUS TUBULE; SERTOLI CELL; SICKLE CELL ANEMIA; SPERMATOZOON; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TESTOSTERONE BLOOD LEVEL;

MUS;

EID: 67649233786     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6031124     Document Type: Article

References (68)

1. Smiley, D.; Dagogo-Jack, S.; Umpierrez, G. Therapy insight: metabolic and endocrine disordrs in sickle cell disease. Nat. Clin. Pract. Metab. 2008, 4, 102-109.
2. Singhal, A.; Thomas, P.; Cook, R.; Wierenga, K.; Serjeant, G. Delayed adolescent growth in homozygous sickle cell disease. Arch. Dis. Child. 1994, 71, 404-408.
3. Modebe, O.; Ifeno, S.A. Growth retardation in homozygous sickle cell disease: role of calorie intake and possible gender related differences. Am. J. Hematol. 1993, 44,149-154.
4. Rogers, Z.R. Priapism in sickle cell disease. Hematol. Oncol. Clin. North Am. 2005, 19, 917-928.
5. Li, M.; Forgarty, J.; Whitney, K.D.; Stone, P. Repeated testicular infarction in a patient with sickle cell disease: a possible mechanism for testicular failure. Urology 2003, 62, 551.
6. Modebe, O.; Eze, U. Effect of age on testicular function in adult males with sickle cell anemia. Fertil. Steril. 1995, 63, 907-912.
7. King, B.S. A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction. J. Clin. Invest. 2003, 111, 171-172.
8. Charache, S.; Terrin, M.L.; Moore, R.D.; Dover, G.J.; Barton, F.B.; Eckert, S.V.; McMahon, R.P.; Bonds, D.R. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 1995, 332, 1317-1322.
9. Charache, S.; Barton, F.B.; Moore, R.D.; Terrin, M.L.; Steinberg, M.H.; Dover, G.J.; Ballas, S.K.; McMahon, R.P.; Castro, O.; Orringer, E.P. Hydroxyurea and sickle cell anemia: clinical utility of a myelosuppressive "switching" agent. Medicine 1996, 75, 300-326.
10. Cokic, V.P.; Smith, R.D.; Beleslin-Cokic, B.B.; Njoroge, J.M.; Miller, J.L.; Gladwin, M.T.; Schechter, A.N. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J. Clin. Invest. 2003, 111, 171-172.
11. Yarbro, J.W. Mechanism of action of hydroxyurea. Semin. Oncol. 1992, 19, 1-10.
12. Fiscor, G.; Ginsberg, L.C. The effect of hydroxyurea and mitomycin C on sperm mobility in mice. Mutat. Res. 1980, 70, 383-387.
13. Evenson, D.P.; Jost, L.K. Hydroxyurea alters mouse testicular kinetics and sperm chromatin structure. Cell Prolif. 1993, 26, 147-159.
14. Wiger, R.; Hongslo, J.K.; Evenson, D.P.; de Angelis, P.; Schwarze, P.E.; Holme, J.A. Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory mice. Reprod. Toxicol. 1995, 9, 21-33.
15. Lu, C.C.; Meistrich, M.L. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res. 1979, 39, 3575-3582.
16. Singh, H.; Taylor, C. Effects of thiotepa and hydroxyurea on sperm production in Lakeview hamsters. J. Toxicol. Environ. Health 1981, 8, 307-316.
17. Wyrobek, A.J.; Bruce, W.R. Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci. U.S.A. 1975, 72, 4425-4429.
18. Shin, J.H.; Mori, C.; Shiota, K. Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment. Toxicol. Appl. Pharmacol. 1999, 155, 139-149.
19. Garozzo, G.; Disca, S.; Fidone, C.; Bonomo, P. Azoospermia in a patient with sickle cell disease treated with hydroxyurea. Haematologica 2000, 85, 1216-1218.
20. Grigg, A. Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease. Intern. Med. J. 2007, 37, 190-192.
21. Berthaut, I.; Guignedoux, G.; Kirsch-Noir, F.; de Larouziere, V.; Ravel, C.; Bachir, D.; Galactéros, F.; Ancel, P.Y.; Kunstmann, J.M.; Levy, L.; Jouannet, P.; Girot, R.; Mandelbaum, J. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica 2008, 93, 988-993.
22. Kopsombut, P.; Mukherjee, S.; Roa, D.P.; Turner, E.A.; Powell, A.; Ademoyero, A.A.; Das, S.K.; Archibong, A.E. Hydroxyurea and indices of male fertility. Adv. Reprod. 2000, 4, 9-32.
23. Popp, R.A.; Popp, D.M.; Shinpock, S.G.; Yang, M.Y.; Mural, J.G.; Aguinaga, M.P.; Kopsombut, P.; Roa, P.D.; Turner, E.A.; Rubin, E.M. A transgenic mouse model of hemoglobin s Antilles disease. Blood 1997, 89, 4204-4212.
24. Rubin, E.M.; Witkowska, H.E. Hypoxia-induced in vitro sickling of transgenic mouse red cells. J. Clin. Invest. 1991, 87, 639-647.
25. Archibong, A.E.; Ramesh, A.; Niaz, M.S.; Brook, C.M.; Roberson, S.I.; Lunstra, D.D. Effects of Benzo(a)pyrene on intra-testicular function in F-344 rats. Int. J. Environ. Res. Public Health 2008, 5, 32-40.
26. Whiten, W.K. Nutrient requirements for the culture of preimplantation mouse embryos in vitro. Adv. Biosci. 1971, 6, 129-139.
27. Filler, R. Methods for evaluation of rat epididymal sperm morphology. In Male Reproductive Toxicology, Part A; Heindel, J.J., Chapin, R.E., Eds.; Academic Press: New York, USA, 1993; Volume 3, pp. 334-343.
28. Inyang, F.; Ramesh, A.; Kopsombut, P.; Niaz, M.S.; Hood, D.B.; Nyanda, A.M.; Archibong, A.E. Disruption of testicular steroidogenesis and epididymal function by inhaled benzo(a)pyrene. Reprod. Toxicol. 2003, 17, 527-537.
29. Rugh, R. The mouse: its reproduction and development; Burgess Publishing Co.: Minneapolis Minn., USA, 1968; pp. 7-43.
30. Lunstra, D.D.; Wise, T.H.; Ford, J.J. Sertoli cells in the boar testis: Changes during development and compensatory hypertrophy after hemicastration at different ages. Biol. Reprod. 2003, 68, 140-150.
31. Steel, R.G.D.; Torrie, J.H. Principles and procedures of statistics: A biometrical approach, 2nd Ed.; McGraw-Hill Book Co.: New York, NY, USA, 1980; pp. 87-343.
32. Lipshultz, L.I.; Witt M.A. Infertility in the male. In Infertility, a practical guide for the physician, 3rd Ed.; Hammond, M.G., Talbert, L.M., Eds.; Blackwell Scientific Publications: Boston, MA, USA; pp. 26-55.
33. Jones, R. Sperm survival versus degradation in mammalian epididymis: A hypothesis. Biol. Reprod. 2004, 71, 1412-1418
34. . 34. Pham, P.T.; Pham, P.C.; Wilkinson, A.H.; Lew, S.Q. Renal abnormalities in sickle cell disease. Kidney Int. 2000, 57, 1-8.
35. Bauer, T.W.; Moore, G.W.; Hutchins, G.M. The liver in sickle cell disease. A chlinicopathologic study of 70 patients. Am. J. Med. 1980, 69, 833-837.
36. Johnson, C.S.; Omata, M.; Tong, M.J.; Simmons, J.F., Jr.; Weiner, J.; Tatter, D. Liver involvement in sickle cell disease. Medicine 1985, 64, 349-356.
37. Sikka, S.C. Role of oxidative stress and antioxidants in andrology and assisted reproductive technology. J. Androl. 2004, 25, 5-18.
38. Donnelly, E.T.; Lewis, S.E.; McNally, J.A.; Thompson, W. In vitro fertilization and pregnancy rates: The influence of sperm motility and morphology on IVF outcome. Fertil. Steril. 1998, 70, 305-314.
39. Jouannet, P.; Ducot, B.; Feneux D.; Spira, A. Male factors and the likelihood of pregnancy in infertile couples. I. Study of sperm characteristics. Int. J. Androl. 1988, 11, 379-384.
40. Perreault, S.D. The mature spermatozoa as a target for reproductive toxicants. In Reproductive and Endocrine Toxicology; Boekelheide, K., Chapin R.E., Hoyer P.B., Harris, C., Eds.; Comprehensive Toxicology, Pergamon Press: New York, NY, USA, 1997; Volume 10, pp. 165-179.
41. Fibach, E.; Rachmilewitz, E. The role of oxidative stress in hemolytic anemia. Curr. Mol. Med. 2008, 8, 609-619.
42. Yu, L.K.; Gengaro, P.E.; Niederberger, M.; Burke, T.J.; Schrier R.W. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1691-1695.
43. Wildhirt, S.M.; Suzuki, H.; Wolf, W.P.; Dudek, R.; Horstman, D.; Weismueller, S.; Reichart, B. S-Methylisothiourea Inhibits Inducible Nitric Oxide Synthase and Improves Left Ventricular Performance after Acute Myocardial Infarction. Biochem. Biophys. Res. Commun. 1996, 227, 328-333.
44. Isobe, M.; Katsuramaki, T.; Hirata, K.; Kimura, H.; Nagayama, M.; Matsuno, T. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999, 68, 803-813.
45. Isobe, M.; Katsuramaki, T.; Kimura, H.; Nagayama, M.; Matsuno, T.; Yagihashi, A.; Hirata, K. Role of inducible nitric oxide synthase on hepatic ischemia and reperfusion injury. Transplant. Proc. 2000, 32, 1650-1652.
46. Farombi, E.O.; Ugwuezunmba, M.C.; Ezenwadu, T.T.; Oyeyemi, M.O.; Ekor, M. Tetracycline-induced reproductive toxicity in male rats: Effects of vitamin C and N-acetylcysteine. Exp. Toxicol. Pathol. 2008, 60, 77-85.
47. Aitken, R.J.; Harkiss, D.; Buckingham, D. Relationship between iron-catalyzed lipid peroxidation and human sperm function. J. Reprod. Fertil. 1993, 98, 257-265.
48. Klinefelter G.R. The epididymis as a target for toxicants. In Reproductive and Endocrine Toxicology; Boekelheide, K., Chapin R.E., Hoyer P.B., Harris, C., Eds.; Comprehensive Toxicology, Pergamon Press: New York, NY, USA, 1997; Volume 10, pp. 151-163.
49. Guthrie, H.D.; Welch, G.R.; Long, J.A. Mitochondrial function and reactive oxygen species action in relation to boar motility. Theriogenology 2008, 70, 1209-1215.
50. Miller, R.P. Degradation of spermatozoa in the epididymis of a seasonally breeding mammal, the rock hyrax, Procavia capensis. J. Reprod. Fertil. 1972, 30, 447-450.
51. El Hamzi, T.H.J.; Bahakim, H.M.; Al-Fawaz, I. Endocrine functions in sickle cell anemia patients. J. Trop. Pediatr. 1992, 38, 307-313.
52. Roger, Z.R. Hydroxyurea for diverse pediatric populations with sickle cell disease. Semin. Hematol. 1997, 34, 42-47.
53. Hackney, A.C.; Hezier, W.; Gulledge, T.P.; Jones, S.; Strayhorn, D.; Busby, M.; Hoffman, E.; Orringer, E.P. Effects of hydroxyurea administration on the body weight, body composition and exercise performance of patients with sickle cell anemia. Clin. Sci. (Lond). 1997, 92, 481-486.
54. Florensa, R.; Bachs, O.; Agell, N. ATM/ATR-independent inhibition of cyclin B accumulation in response to hydroxyurea in nontransformed cell lines is altered in tumor cell lines. Oncogene 2003, 13, 8283-8292.
55. Lamanna, C.; Assisi, L.; Vittoria, A.; Botte, V.; Di Fiore, M.M. d-Aspartic acid and nitric oxide as regulators of androgen production in boar testis. Theriogenology 2006, 67, 249-254.
56. Huang, J.; Yakubu, M.; Kim-Shapiro, D.B.; King, B. Rat liver-mediated metabolism of hydroxyurea to nitric oxide. Free Radical Biol. Med. 2006, 40, 1675-1681.
57. Reiter, C.D.; Gladwin, M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 2003, 10, 99-107.
58. Reiter, C.D.; Wang, J.; Tanus-Santos, X.E.; Hogg, N.; Cannon, R.O.; Schechter, A.N.; Gladwin, M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle cell disease. Nat. Med. 2002, 8, 1383-1389.
59. Aslan, M.; Ryan, T.M.; Adler, B.; Townes, T.M.; Parks, D.A.; Thompson, J.A.; Tousson, A.; Gladwin, M.T.; Patel, R.P.; Tarpey, M.M.; White, R.C.; Freeman R.C. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. 2001, 98, 15215-15220.
60. Cokic, V.P.; Smith, R.D.; Beleslin-Cokic, B.B.; Njoroge, J.M.; Miller, J.L.; Gladwin, M.T.; Schechter, A.N. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J. Clin. Invest. 2003, 111, 231-239.
61. Singh, H.; Tate, F. Antispermatogenic effects of ethylmethane sulfonate and benzo(a)pyrene on PD4 Lakeview hamsters. J. Toxicol. Environ. Health 1981, 8, 929-937.
62. Revel, A.; Roanani, H.; Younglai, E.; Xu, J.; Han, R.; Savouret J-F.; Casper, R.F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects sperm from DNA damage and apoptosis caused by benzo(a)pyrene. Reprod. Toxicol. 2001, 15, 479-486.
63. Plant, T.M.; Marshall, G.R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr. Rev. 2001, 22, 764-786.
64. Balercia, G.; Moretti, S.; Vignini, A.; Magagnini, M.; Mantero, F.; Boscaro, M.; Ricciardo-Lamonica, G.; Mazzanti, L. Role of nitric oxide concentrations on human sperm motility. J. Androl. 2004, 25, 245-249.
65. Li, X.; Nokkala, E.; Yan, W.; Streng, T.; Saarinen, N.; Warri, A.; Huhtaniemi, I.; Santti, R.; Makela, N.; Poutanen, M. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001, 142, 2435-2442.
66. Dobashi, M.; Fujisawa, M.; Yamazaki, T.; Okuda, Y.; Kanzaki, M.; Tatsumi, N.; Tsuji, T.; Okada, H.; Kamidono, S. Inhibition of steroidogenesis in Leydig cells by exogenous nitric oxide occurs independently of steroidogenic acute regulatory protein (StAR) mRNA. Arch. Androl. 2001, 47, 203-209.
67. Kostic, T.S.; Andric, S.A.; Maric, D.; Stojilkovic, S.S.; Kovacevic, R. Involvement of inducible nitric oxide synthase in stress-impaired testicular steroidogenesis. J. Endocrinol. 1999, 163, 409-416.
68. Pomerantz, D.K.; Petelka, V. Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse. Endocrinology 1998, 139, 922-931.